Targeted News Service

Alzheimer's Association Statement on Topline Results from the CELIA Phase 2 Clinical Trial of Tau-Targeting Therapy Diranersen (BIIB080)
May 14, 2026

CHICAGO, Illinois, May 14 [Category: Health Care] -- The Alzheimer's Association posted the following news release:

* * *

Alzheimer's Association Statement on Topline Results from the CELIA Phase 2 Clinical Trial of Tau-Targeting Therapy Diranersen (BIIB080)

*

New phase 2 clinical trial results testing a treatment targeting tau in individuals living with early-stage Alzheimer's disease were released today, marking important progr . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form